Adverse events account for less than 10% of 1-800 calls on OTCs -- NDMA survey.
This article was originally published in The Tan Sheet
Executive Summary
ADVERSE EVENTS ACCOUNT FOR LESS THAN 10% OF OTC 1-800 CALLS on average, according to a Nonprescription Drug Manufacturers Association survey of 18 member companies. Conducted this fall, the survey involved companies marketing varying types and quantities of OTC product lines. NDMA reported the survey results at its annual Research & Scientific Development Conference held Nov. 12-13 in Washington, D.C. during a workshop entitled: "Listening to the Consumer: The Value of 1-800 Numbers."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning